PTC Therapeutics (PTCT) Positive Data from FIREFISH Study of Evrysdi in Infants with Type 1 SMA Published in NEJM

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to PTC Therapeutics (PTCT) Positive Data from FIREFISH Study of Evrysdi in Infants with Type 1 SMA Published in NEJM

PTC Therapeutics (PTCT) Misses Q4 EPS by 14c, Revenues Beat

February 25, 2021 5:13 PM EST

PTC Therapeutics (NASDAQ: PTCT) reported Q4 EPS of ($1.08), $0.14 worse than the analyst estimate of ($0.94). Revenue for the quarter came in at $118.86 million versus the consensus estimate of $111.36 million.

"Despite the challenges of the pandemic, PTC has been able to make significant... More